These features suggest that IDH2-mutant AML cells are sensitive to the differentiation inducing activity of ATRA (all-trans retinoic acid) and to the proapoptotic effect of arsenic trioxide (ATO). The gene discussed is IDH2; the disease is acute myeloid leukemia.